Blood coagulation factor XIII: structure and function.
暂无分享,去创建一个
V. Yee | L Muszbek | V C Yee | Z Hevessy | Z. Hevessy | L. Muszbek | L. Muszbek | Vivien C. Yee | Zsuzsa Hevessy
[1] J. Fachet,et al. A Simple, Quick One-step ELISA Assay for the Determination of Complex Plasma Factor XIII (A2B2) , 2000, Thrombosis and Haemostasis.
[2] B. A. Fox,et al. Identification of the Calcium Binding Site and a Novel Ytterbium Site in Blood Coagulation Factor XIII by X-ray Crystallography* , 1999, The Journal of Biological Chemistry.
[3] F. Brosstad,et al. Platelet adhesion and plasmin generation on immobilized and FXIII crosslinked fibrin(ogen) , 1998 .
[4] P. Board,et al. The Val34Leu polymorphism in the A subunit of coagulation factor XIII contributes to the large normal range in activity and demonstrates that the activation peptide plays a role in catalytic activity. , 1998, Blood.
[5] P. McKee,et al. Effect of Phenylglyoxal-modified α2-Antiplasmin on Urokinase-induced Fibrinolysis , 1998, Thrombosis and Haemostasis.
[6] L. Mccormack,et al. Prevalence of FXIII V34L in Populations with Different Cardiovascular Risk , 1998, Thrombosis and Haemostasis.
[7] D. Nurminsky,et al. Plasma Transglutaminase in Hypertrophic Chondrocytes: Expression and Cell-specific Intracellular Activation Produce Cell Death and Externalization , 1998, The Journal of cell biology.
[8] G. Melino,et al. Inhibition of clotting factor XIII activity by nitric oxide. , 1998, Biochemical and Biophysical Research Communications - BBRC.
[9] R. Willette,et al. Factor XIIIa cross-links lipoprotein(a) with fibrinogen and is present in human atherosclerotic lesions. , 1998, Circulation research.
[10] G. Chelvanayagam,et al. A novel Asn344 deletion in the core domain of coagulation factor XIII A subunit: its effects on protein structure and function. , 1998, Blood.
[11] W. Thompson,et al. Effect of Crosslinking by Factor XIIIa on the Migration of Vascular Smooth Muscle Cells into Fibrin Gels , 1998 .
[12] J. Takamatsu,et al. Arg260‐Cys mutation in severe factor XIII deficiency: conformational change of the A subunit is predicted by molecular modelling and mechanics , 1998, British journal of haematology.
[13] F. Rodeghiero,et al. Molecular mechanisms of type II factor XIII deficiency: novel Gly562-Arg mutation and C-terminal truncation of the A subunit cause factor XIII deficiency as characterized in a mammalian expression system. , 1998, Blood.
[14] M. Weiss,et al. Two non‐proline cis peptide bonds may be important for factor XIII function , 1998, FEBS letters.
[15] A. Carter,et al. Association of a Common Polymorphism in the Factor XIII Gene with Myocardial Infarction , 1998, Thrombosis and Haemostasis.
[16] C. Greenberg,et al. Analysis of Factor XIII Substrate Specificity Using Recombinant Human Factor XIII and Tissue Transglutaminase Chimeras* , 1997, The Journal of Biological Chemistry.
[17] J. Schwarzbauer,et al. Covalent Cross-linking of Fibronectin to Fibrin Is Required for Maximal Cell Adhesion to a Fibronectin-Fibrin Matrix* , 1997, The Journal of Biological Chemistry.
[18] V. Yee,et al. Structural analysis of a missense mutation (Val414Phe) in the catalytic core domain of the factor XIIIA subunit , 1997, British journal of haematology.
[19] C. Arocha-Piñango,et al. Degradation of human factor XIII by lonomin V, a purified fraction of Lonomia achelous caterpillar venom. , 1997, Thrombosis research.
[20] Mosesson Mw. Fibrinogen and fibrin polymerization: appraisal of the binding events that accompany fibrin generation and fibrin clot assembly. , 1997 .
[21] C. Arocha-Piñango,et al. Lonomia achelous caterpillar venom (LACV) selectively inactivates blood clotting factor XIII. , 1997, Thrombosis research.
[22] V. Yee,et al. Factor XIII Deficiency due to a Leu660Pro Mutation in the Factor XIII Subunit-a Gene in Three Unrelated Palestinian Arab Families , 1997, Thrombosis and Haemostasis.
[23] A. Palotie,et al. Molecular Mechanisms of Mutations in Factor XIII A-subunit Deficiency: In vitro Expression in COS-cells Demonstrates Intracellular Degradation of the Mutant Proteins , 1997, Thrombosis and Haemostasis.
[24] L. Peltonen,et al. Molecular mechanism of a mild phenotype in coagulation factor XIII (FXIII) deficiency: a splicing mutation permitting partial correct splicing of FXIII A-subunit mRNA. , 1997, Blood.
[25] J. Takagi,et al. Dual functions of transglutaminase in novel cell adhesion. , 1996, Journal of cell science.
[26] L. Henke,et al. Novel polymorphisms and haplotypes in the human coagulation factor XIII A-subunit gene , 1996, Human Genetics.
[27] K. Siebenlist,et al. Plasma factor XIII binds specifically to fibrinogen molecules containing gamma chains. , 1996, Biochemistry.
[28] R. Ádány,et al. Three Different Cell Types Can Synthesize Factor XIII Subunit A in the Human Liver , 1996, Thrombosis and Haemostasis.
[29] B. Blombäck. Fibrinogen and fibrin--proteins with complex roles in hemostasis and thrombosis. , 1996, Thrombosis research.
[30] D. Foster,et al. Expression and release of the a and b subunits for human coagulation factor XIII in baby hamster kidney (BHK) cells. , 1996, Journal of biochemistry.
[31] M. Udvardy,et al. Promotion of the Crosslinking of Fibrin and α2-antiplasmin by Platelets , 1996, Thrombosis and Haemostasis.
[32] J. Mcdonagh,et al. Determinants of Substrate Specificity for Factor XIII , 1996, Seminars in thrombosis and hemostasis.
[33] S. I. Chung,et al. Factors That Control Extravascular Fibrinolysis , 1996, Seminars in thrombosis and hemostasis.
[34] D. Devine,et al. Platelet-Associated Factor XIII in Platelet Activation, Adhesion, and Clot Stabilization , 1996, Seminars in thrombosis and hemostasis.
[35] F. Dapper,et al. Factor XIII in Ulcerative Leg Disease: Background and Preliminary Clinical Results , 1996, Seminars in thrombosis and hemostasis.
[36] R. Ádány. Intracellular Factor XIII: Cellular Distribution of Factor XIII Subunit a in Humans , 1996, Seminars in thrombosis and hemostasis.
[37] S. I. Chung,et al. Fibrin Degradation in the Synovial Fluid of Rheumatoid Arthritis Patients: A Model for Extravascular Fibrinolysis , 1996, Seminars in thrombosis and hemostasis.
[38] L. Peltonen,et al. Four novel mutations in deficiency of coagulation factor XIII: consequences to expression and structure of the A-subunit. , 1996, Blood.
[39] A. Stewart,et al. Molecular basis of inherited factor XIII deficiency: identification of multiple mutations provides insights into protein function , 1995, British journal of haematology.
[40] J. Hainfeld,et al. Orientation of the Carboxy-terminal Regions of Fibrin γ Chain Dimers Determined from the Crosslinked Products Formed in Mixtures of Fibrin, Fragment D, and Factor XIIIa , 1995, Thrombosis and Haemostasis.
[41] V. Yee,et al. Factor XIIIA calgary: a candidate missense mutation (Leu667Pro) in the beta barrel 2 domain of the factor XIIIA subunit , 1995, British journal of haematology.
[42] E. Bendixen,et al. Location of the Major -(-Glutamyl)lysyl Cross-linking Site in Transglutaminase-modified Human Plasminogen (*) , 1995, The Journal of Biological Chemistry.
[43] L. Pedersen,et al. Structural evidence that the activation peptide is not released upon thrombin cleavage of factor XIII. , 1995, Thrombosis research.
[44] M. Packham,et al. Platelet Accumulation on Fibrin-coated Polyethylene: Role of Platelet Activation and Factor XIII , 1995, Thrombosis and Haemostasis.
[45] A. Ichinose,et al. Molecular and cellular basis of deficiency of the b subunit for factor XIII secondary to a Cys430-Phe mutation in the seventh Sushi domain. , 1995, The Journal of clinical investigation.
[46] I. Kurochkin,et al. Domain structure, stability and domain-domain interactions in recombinant factor XIII. , 1995, Journal of molecular biology.
[47] L. Muszbek,et al. Transformation of Cellular Factor XIII into an Active Zymogen Transglutaminase in Thrombin-Stimulated Platelets , 1995, Thrombosis and Haemostasis.
[48] M. Mendelsohn,et al. Specific binding of the transglutaminase, platelet factor XIII, to HSP27. , 1994, The Journal of biological chemistry.
[49] R. Ádány,et al. Onset and distribution of factor XIII-containing cells in the mesenchyme of chorionic villi during early phase of human placentation. , 1994, Placenta.
[50] L. Pedersen,et al. Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[51] L. Peltonen,et al. Deficiency in the A-subunit of coagulation factor XIII: two novel point mutations demonstrate different effects on transcript levels. , 1994, Blood.
[52] L. Pedersen,et al. Transglutaminase factor XIII uses proteinase‐like catalytic triad to crosslink macromolecules , 1994, Protein science : a publication of the Protein Society.
[53] G. Matsueda,et al. Role of histidine 373 in the catalytic activity of coagulation factor XIII. , 1994, The Journal of biological chemistry.
[54] D. Devine,et al. Factor XIIIa binding to activated platelets is mediated through activation of glycoprotein IIb-IIIa. , 1994, Blood.
[55] C. Francis,et al. Determination of the topology of factor XIIIa-induced fibrin gamma-chain cross-links by electron microscopy of ligated fragments. , 1993, The Journal of biological chemistry.
[56] M. Losowsky,et al. Factor XIII: inherited and acquired deficiency. , 1993, Blood reviews.
[57] B. Bouma,et al. Cross‐linking of &agr;2‐antiplasmin to fibrin is a key factor in regulating blood clot lysis: species differences , 1993, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[58] P. Holme,et al. The Difference Between Platelet and Plasma FXIII Used to Study the Mechanism of Platelet Microvesicle Formation , 1993, Thrombosis and Haemostasis.
[59] E. Bendixen,et al. Transglutaminases catalyze cross-linking of plasminogen to fibronectin and human endothelial cells. , 1993, The Journal of biological chemistry.
[60] M. Dianzani,et al. Lipid peroxidation and cancer. , 1993, Critical reviews in oncology/hematology.
[61] R. Gorodetsky,et al. Packaging zinc, fibrinogen, and factor XIII in platelet α‐granules , 1993 .
[62] N. Aoki. Clot Retraction Increases Clot Resistance to Fibrinolysis by Condensing α2-Plasmin Inhibitor Crosslinked to Fibrin , 1993, Thrombosis and Haemostasis.
[63] B. Caeiro,et al. An alternative modality for the immunodetection of the molecular phenotypes of coagulation factor XIIIB. , 1993, Human heredity.
[64] D. Devine,et al. Platelet-associated factor XIII as a marker of platelet activation in patients with peripheral vascular disease. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.
[65] L. Zacharski,et al. Fibrin and Cancer , 1993, Thrombosis and Haemostasis.
[66] L. Lorand,et al. Type-2 plasminogen-activator inhibitor is a substrate for trophoblast transglutaminase and factor XIIIa. Transglutaminase-catalyzed cross-linking to cellular and extracellular structures. , 1993, European journal of biochemistry.
[67] A. Johnsen,et al. Different N-terminal forms of α2-plasmin inhibitor in human plasma , 1993 .
[68] L. Lorand,et al. Association of the A subunits of recombinant placental factor XIII with the native carrier B subunits from human plasma. , 1993, Biochemistry.
[69] Z. Boda,et al. Platelet Factor XIII Becomes Active without the Release of Activation Peptide during Platelet Activation , 1993, Thrombosis and Haemostasis.
[70] Y. Matsuda,et al. Molecular cloning of the b subunit of mouse coagulation factor XIII and assignment of the gene to chromosome 1: close evolutionary relationship to complement factor H. , 1993, Genomics.
[71] D. Macdonald,et al. The tissue distribution of factor XIIIa positive cells , 1993, Histopathology.
[72] L. Lorand,et al. Human plasma factor XIII: subunit interactions and activation of zymogen. , 1993, Methods in enzymology.
[73] A. Bennick,et al. Early cross‐linked fibrin in human plasma contains α‐polymers with intact fibrinopeptide A , 1992 .
[74] G. Reed,et al. Platelet Factor XIII Increases the Fibrinolytic Resistance of Platelet-Rich Clots by Accelerating the Crosslinking of α2-Antiplasmin to Fibrin , 1992, Thrombosis and Haemostasis.
[75] H. Cleve,et al. Serum protein polymorphisms in Arab Moslems and Druze of Israel: BF, F13B, AHSG, GC, PLG, PI, and TF. , 1992, Human biology.
[76] C. Dunwiddie,et al. Pathways of coagulation activation in situ in rheumatoid synovial tissue. , 1992, Clinical immunology and immunopathology.
[77] H. Cleve,et al. Genetic serum protein polymorphisms in Jordanian Arabs: a pilot study of the systems AHSG, BF, F XIII B, GC, PI, PLG and TF. , 1992, Gene geography : a computerized bulletin on human gene frequencies.
[78] J. Murray,et al. A tetranucleotide repeat for the F13B locus. , 1992, Nucleic acids research.
[79] R. Ádány,et al. Marker profile, enzyme activity, and function of a human myelomonocytic leukemia cell line. , 1992, Cellular immunology.
[80] S. Easteal,et al. Genetic affinities of oceanic populations based on RFLP and haplotype analysis of genetic loci on three chromosomes. , 1992, Human biology.
[81] K. Siebenlist,et al. Factors affecting gamma-chain multimer formation in cross-linked fibrin. , 1992, Biochemistry.
[82] J. Shafer,et al. Interactions of factor XIII with fibrin as substrate and cofactor. , 1992, Biochemistry.
[83] Factor XIII-dependent generation of 5th complement component(C5)-derived monocyte chemotactic factor coinciding with plasma clotting. , 1992, Biochimica et biophysica acta.
[84] Mosesson Mw. The assembly and structure of the fibrin clot. , 1992 .
[85] K. Siebenlist,et al. Factors affecting γ-chain multimer formation in cross-linked fibrin , 1992 .
[86] Z. Nemes. Differentiation markers in hemangiopericytoma , 1992 .
[87] G. Asijee,et al. Cytoskeletal assembly and vinculin-cytoskeleton interaction in different phases of the activation of bovine platelets. , 1992, Cell motility and the cytoskeleton.
[88] N. Saha,et al. Population genetics of coagulation factor XIIIB in three ethnic groups of Singapore. , 1992, Annals of human biology.
[89] J. Meunier,et al. Purification and properties of factor XIII from human placenta. , 1992, The International journal of biochemistry.
[90] M. Mendelsohn,et al. The 29-kDa proteins phosphorylated in thrombin-activated human platelets are forms of the estrogen receptor-related 27-kDa heat shock protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[91] V. Chang,et al. Lipoprotein (a) is a substrate for factor XIIIa and tissue transglutaminase. , 1991, The Journal of biological chemistry.
[92] L. Pedersen,et al. Expression and characterization of human factor IX. Factor IXthr-397 and factor IXval-397. , 1991, The Journal of biological chemistry.
[93] D. S. Rath,et al. Tetranucleotide repeat polymorphism at the human coagulation factor XIII A subunit gene (F13A1). , 1991, Nucleic acids research.
[94] D. S. Rath,et al. Trinucleotide repeat polymorphism at the human met-tRNA-i gene 1 (TRMI). , 1991, Nucleic acids research.
[95] C. W. Prince,et al. Osteopontin, a substrate for transglutaminase and factor XIII activity. , 1991, Biochemical and biophysical research communications.
[96] J. Shafer,et al. Role of calcium ion in the generation of factor XIII activity. , 1991, Biochemistry.
[97] C. M. Cohen,et al. Organization of the gene for human erythrocyte membrane protein 4.2: structural similarities with the gene for the a subunit of factor XIII. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[98] J. Shainoff,et al. Immunoelectrophoretic characterizations of the cross-linking of fibrinogen and fibrin by factor XIIIa and tissue transglutaminase. Identification of a rapid mode of hybrid alpha-/gamma-chain cross-linking that is promoted by the gamma-chain cross-linking. , 1991, The Journal of biological chemistry.
[99] E. Tarcsa,et al. The presence of a covalently cross-linked matrix in human platelets. , 1991, Biochimica et biophysica acta.
[100] J. Voorhees,et al. Proliferating cells in psoriatic dermis are comprised primarily of T cells, endothelial cells, and factor XIIIa+ perivascular dendritic cells. , 1991, The Journal of investigative dermatology.
[101] L. Lorand,et al. Characterization of the kinetic pathway for fibrin promotion of alpha-thrombin-catalyzed activation of plasma factor XIII. , 1991, Biochemistry.
[102] H. Nishimukai,et al. Polymorphisms of serum proteins in Japanese patients with vascular diseases. I. Factor XIIIB, plasminogen and complement types in primary varicose veins. , 1991, Human heredity.
[103] R. Pascone,et al. Genetic polymorphisms of the A and B subunits of human coagulation factor XIII in mainland Italy and Sardinia: Description of a new FXIIIA variant allele , 1991, Electrophoresis.
[104] E. Davie,et al. Nucleotide sequence of the gene for the b subunit of human factor XIII. , 1990, Biochemistry.
[105] L. Lorand,et al. Labeling of epsilon-lysine crosslinking sites in proteins with peptide substrates of factor XIIIa and transglutaminase. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[106] D. Teller,et al. Human recombinant factor XIII from Saccharomyces cerevisiae. Crystallization and preliminary x-ray data. , 1990, The Journal of biological chemistry.
[107] E. Davie,et al. Structure of transglutaminases. , 1990, The Journal of biological chemistry.
[108] S. Rodríguez de Córdoba,et al. Physical linkage of the human genes coding for complement factor H and coagulation factor XIII B subunit. , 1990, Genomics.
[109] H. Kikuchi,et al. Effects of blood coagulation factor XIII on the development of experimental cerebral aneurysms in rats. , 1990, Journal of neurosurgery.
[110] A. Stern,et al. Enhanced thrombolysis by a factor XIIIa inhibitor in a rabbit model of femoral artery thrombosis. , 1990, Thrombosis research.
[111] D. Mosher,et al. Binding and degradation of blood coagulation factor XIII by cultured fibroblasts. , 1990, The Journal of biological chemistry.
[112] R. Hilgenfeld,et al. Crystallization of blood coagulation factor XIII by an automated procedure , 1990, FEBS letters.
[113] P. Wiedemann,et al. Blood coagulation factor XIII contributes to the development of traction retinal detachment , 1990, Acta ophthalmologica.
[114] L. Muszbek,et al. Non-proteolytic activation of cellular protransglutaminase (placenta macrophage factor XIII). , 1990, The Biochemical journal.
[115] P. Board,et al. Expression of Functional Coagulation Factor XIII in Escherichia coli , 1990, Thrombosis and Haemostasis.
[116] R. Ádány,et al. Increased density of histiocytes in uterine leiomyomas. , 1990, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[117] A. Stern,et al. Inhibition of factor XIIIa in a canine model of coronary thrombosis: effect on reperfusion and acute reocclusion after recombinant tissue-type plasminogen activator. , 1990, Blood.
[118] P. Højrup,et al. Sequence location of a putative transglutaminase cross‐linking site in human vitronectin , 1990, FEBS letters.
[119] K. Okafuji,et al. A familial factor XIII subunit B deficiency , 1990, British journal of haematology.
[120] D. Teller,et al. Expression, purification, and characterization of human factor XIII in Saccharomyces cerevisiae. , 1990, Biochemistry.
[121] S. Reddy,et al. Synthesis of human coagulation factor XIII in yeast. , 1990, Gene.
[122] P. Wiedemann,et al. Nachweis von Gerinnungsfaktor XIII im Glaskörper und periretinalen Membranen bei proliferativen Netzhauterkrankungen , 1990 .
[123] Piérard Ge,et al. Factor-XIIIa-positive dendrocytes and the dermal microvascular unit. , 1990 .
[124] A. Hamsten,et al. Native fibrin gel networks and factors influencing their formation in health and disease. , 1990, Advances in experimental medicine and biology.
[125] A. Amorim,et al. Formal and population genetics of F13A and FUCA1 polymorphisms in northern Portugal. , 1990, Human heredity.
[126] N. Isogai,et al. Wound healing at the site of microvascular anastomosis: Fibrin‐stabilizing factor XIII administration and its effects , 1990, Microsurgery.
[127] H. Saito,et al. Congenital factor XIII deficiency with treatment of factor XIII concentrate and normal vaginal delivery. , 1990, Gynecologic and obstetric investigation.
[128] R. Colman,et al. Human platelet factor V is crosslinked to actin by FXIIIa during platelet activation by thrombin. , 1990, Thrombosis research.
[129] S. Chien,et al. Fibrinogen, Thrombosis, Coagulation, and Fibrinolysis , 1990, Advances in Experimental Medicine and Biology.
[130] R. Ádány,et al. Factors of the Extrinsic Pathway of Blood Coagulation in Tumour Associated Macrophages , 1989, Thrombosis and Haemostasis.
[131] Francis Jl. Haemostasis and cancer. , 1989 .
[132] O. Miura,et al. Expression and characterization of pro alpha 2-plasmin inhibitor. , 1989, Journal of biochemistry.
[133] N. Penneys,et al. Factor XIIIa is expressed by fibroblasts in fibrovascular tumors * , 1989, Journal of cutaneous pathology.
[134] B. Nickoloff,et al. Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skin , 1989, The British journal of dermatology.
[135] J. Shafer,et al. Alpha-thrombin-catalyzed activation of human platelet factor XIII: relationship between proteolysis and factor XIIIa activity. , 1989, Biochemistry.
[136] H. Takami,et al. Factor XIII is not involved in human platelet-collagen interaction. , 1989, The Tohoku journal of experimental medicine.
[137] M. Poon,et al. Hemopoietic origin of factor XIII A subunits in platelets, monocytes, and plasma. Evidence from bone marrow transplantation studies. , 1989, The Journal of clinical investigation.
[138] K. Achyuthan,et al. Human mononuclear phagocyte transglutaminase activity cross-links fibrin. , 1989, Thrombosis research.
[139] M. Bröker,et al. New expression vectors for the fission yeast Schizosaccharomyces pombe , 1989, FEBS letters.
[140] D. Mosher,et al. Factor XIIIa-mediated cross-linking of fibronectin in fibroblast cell layers. Cross-linking of cellular and plasma fibronectin and of amino-terminal fibronectin fragments. , 1989, The Journal of biological chemistry.
[141] J. Kroll. The subunit composition of factor XIII proteins in normal and factor XIII deficient plasma and serum analysed by line immunoelectrophoresis. , 1989, Clinica chimica acta; international journal of clinical chemistry.
[142] K. Siebenlist,et al. Identification of covalently linked trimeric and tetrameric D domains in crosslinked fibrin. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[143] J. Dyr,et al. Conversion of fibrinogen to fibrin induced by preferential release of fibrinopeptide B. , 1989, Biochimica et biophysica acta.
[144] K. Achyuthan,et al. Tb(III)-ion-binding-induced conformational changes in platelet factor XIII. , 1989, The Biochemical journal.
[145] H. Erickson,et al. Electron microscopy and hydrodynamic properties of factor XIII subunits. , 1989, The Journal of biological chemistry.
[146] B. Morris,et al. The B subunit of coagulation factor XIII is linked to renin and the Duffy blood group to alpha-spectrin on human chromosome 1. , 1989, Human Heredity.
[147] R. Ádány,et al. Congenital factor XIII deficiency with multiple benign breast tumours and successful pregnancy with substitutive therapy. A case report. , 1989, Haemostasis.
[148] R. Ferrell,et al. Genetic studies of low‐abundance human plasma proteins: X. Coagulation factor XIIIB variants in blacks , 1989, Electrophoresis.
[149] B. Nusgens,et al. Factor XIII of blood coagulation modulates collagen biosynthesis by fibroblasts in vitro. , 1989, Haemostasis.
[150] J. Enghild,et al. Isolation of a fibrin-binding fragment from blood coagulation factor XIII capable of cross-linking fibrin(ogen). , 1988, The Biochemical journal.
[151] T. L. Moser,et al. Vitronectin is a substrate for transglutaminases. , 1988, Biochemical and biophysical research communications.
[152] R. Procyk,et al. Factor XIII-induced crosslinking in solutions of fibrinogen and fibronectin. , 1988, Biochimica et biophysica acta.
[153] M. Rabaud,et al. Biochemical study of adduct synthesis between fibrin monomers and elastin. , 1988, Biomaterials.
[154] R. Ádány,et al. Fibrinolysis Resistant Fibrin Deposits in Lymph Nodes with Hodgkin's Disease , 1988, Thrombosis and Haemostasis.
[155] K. Achyuthan,et al. b-chains prevent the proteolytic inactivation of the a-chains of plasma factor XIII. , 1988, Biochimica et biophysica acta.
[156] R. Ádány. Identification of Factor XIIIa in cutaneous tissue , 1988 .
[157] D. Devine,et al. Cytofluorometric Identification of Plasmin-Sensitive Factor XIIIa Binding to Platelets , 1988, Thrombosis and Haemostasis.
[158] T. Halkier,et al. Contact activation of blood coagulation is inhibited by plasma factor XIII b-chain. , 1988, Thrombosis research.
[159] K. Matsui,et al. Polymorphism of the A subunit of coagulation factor XIII: evidence for subtypes of the FXIIIA*1 and FXIIIA*2 alleles. , 1988, American journal of human genetics.
[160] E. Davie,et al. Characterization of the gene for the a subunit of human factor XIII (plasma transglutaminase), a blood coagulation factor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[161] D. Mosher,et al. Factor XIII cross-linking of fibronectin at cellular matrix assembly sites. , 1988, The Journal of biological chemistry.
[162] A. Beaudet,et al. Extensive DNA polymorphism at the factor XIIIa (F13A) locus and linkage to HLA. , 1988, American journal of human genetics.
[163] R. Colman,et al. Covalent crosslinking of human coagulation factor V by activated factor XIII from guinea pig megakaryocytes and human plasma. , 1988, Blood.
[164] P. Board,et al. Haplotypes of the coagulation factor XIII A subunit locus in normal and deficient subjects. , 1988, American journal of human genetics.
[165] C. Francis,et al. Increased resistance to plasmic degradation of fibrin with highly crosslinked alpha-polymer chains formed at high factor XIII concentrations. , 1988, Blood.
[166] J. Takagi,et al. "A" subunit of factor XIII is present on bovine platelet membrane and mediates collagen-induced platelet activation. , 1988, Thrombosis research.
[167] R. Ádány,et al. Monocytes of Patients Congenitally Deficient in Plasma Factor XIII Lack Factor XIII Subunit A Antigen and Transglutaminase Activity , 1988, Thrombosis and Haemostasis.
[168] S. Pizzo,et al. Characterization of the fibrin polymer structure that accelerates thrombin cleavage of plasma factor XIII. , 1988, Archives of biochemistry and biophysics.
[169] H. Dvorak,et al. Macrophage migration in fibrin gel matrices. II. Effects of clotting factor XIII, fibronectin, and glycosaminoglycan content on cell migration. , 1988, Journal of immunology.
[170] R. Ádány,et al. Characterisation of connective tissue cells containing factor XIII subunit a. , 1988, Journal of clinical pathology.
[171] R. Ádány,et al. Intratumoral Fibrin Stabilization , 1988 .
[172] G. Lynch,et al. B protein of factor XIII: differentiation between free B and complexed B. , 1988, Blood.
[173] A. Sturk,et al. Platelet vinculin: a substrate of activated factor XIII. , 1988, Biochimica et biophysica acta.
[174] G. Webb,et al. Localization of the coagulation factor XIII A subunit gene (F13A) to chromosome bands 6p24----p25. , 1988, Cytogenetics and cell genetics.
[175] H. Cleve,et al. Analysis of the genetic polymorphism of coagulation factor XIIIB (FXIIIB) by isoelectric focusing , 1988, Electrophoresis.
[176] L. Patthy,et al. Detecting homology of distantly related proteins with consensus sequences. , 1987, Journal of molecular biology.
[177] R. Ádány,et al. Cells containing Factor VIII subunit a in benign and soft tissue tumours , 1987, Histopathology.
[178] D. Dykes,et al. The use of the serum protein factor XIIIB (F XIIIB) in parentage testing. , 1987, American journal of clinical pathology.
[179] C. Francis,et al. RAPID FORMATION OF LARGE MOLECULAR WEIGHT O-P0LYMERS IN CROSSLINKED FIBRIN INDUCED BY HIGH FACTOR XIII CONCENTRATIONS: ROLE OF PLATELET FACTOR XIII. , 1987, Thrombosis and Haemostasis.
[180] R. Ádány,et al. Expression of factor xiii subunit a in different types of human macrophages , 1987 .
[181] R. Ádány,et al. Factor XIII: a marker of mono‐ and megakaryocytopoiesis , 1987, British journal of haematology.
[182] K. Achyuthan,et al. Factor XIII binds to the Aα- and Bβ- chains in the D-domain of fibrinogen: An immunoblotting study , 1987 .
[183] M. Shuman,et al. Identification of normal human peripheral blood monocytes and liver as sites of synthesis of coagulation factor XIII a-chain. , 1987, Blood.
[184] R. Kannagi,et al. Platelet factor XIII is activated by calpain. , 1987, Biochemical and biophysical research communications.
[185] C. Kluft,et al. Influence of Factor Xllla Activity on Human Whole Blood Clot Lysis In Vitro , 1987, Thrombosis and Haemostasis.
[186] R. Ádány,et al. Erratum , 1998, Environmental Health Perspectives.
[187] K. Achyuthan,et al. Factor XIIIa formation promoted by complexing of alpha-thrombin, fibrin, and plasma factor XIII. , 1987, Blood.
[188] R. Colvin,et al. Factor XIII A is synthesized and expressed on the surface of U937 cells and alveolar macrophages. , 1987, Blood.
[189] G. Lynch,et al. Characterization of thrombospondin as a substrate for factor XIII transglutaminase. , 1987, The Journal of biological chemistry.
[190] A. Wölpl,et al. COAGULATION FACTOR XIII A AND B SUBUNITS IN BONE MARROW AND LIVER TRANSPLANTATION , 1987, Transplantation.
[191] R. Ádány,et al. Selective visualization of human dendritic reticulum cells in reactive lymphoid follicles by the immunohistochemical demonstration of the subunit A of factor XIII (F-XIIIa) , 1986, Virchows Archiv. B, Cell pathology including molecular pathology.
[192] M. Carr,et al. Influence of factor XIII and fibronectin on fiber size and density in thrombin-induced fibrin gels. , 1987, The Journal of laboratory and clinical medicine.
[193] L. Lorand. Activation of Blood Coagulation Factor XIII a , 1986, Annals of the New York Academy of Sciences.
[194] R. Ferrell,et al. Genetic studies of low abundance human plasma proteins. II. Population genetics of coagulation factor XIIIB. , 1986, American journal of human genetics.
[195] C. Lapière,et al. The lack of attachment of transformed embryonic lung epithelial cells to collagen I is corrected by fibronectin and FXIII. , 1986, Journal of cell science.
[196] S. Kimura,et al. Cross-linking site in fibrinogen for alpha 2-plasmin inhibitor. , 1986, The Journal of biological chemistry.
[197] K. Fujikawa,et al. Amino acid sequence of the a subunit of human factor XIII. , 1986, Biochemistry.
[198] C. Bird,et al. Immunohistological demonstration of factors XIIIa and XIIIs in reactive and neoplastic fibroblastic and fibro‐histiocytic lesions , 1986, Histopathology.
[199] Y. Takahashi,et al. Primary structure of blood coagulation factor XIIIa (fibrinoligase, transglutaminase) from human placenta. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[200] E. Amann,et al. Characterization of cDNA coding for human factor XIIIa. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[201] D. Mosher,et al. Thrombospondin is a substrate for blood coagulation factor XIIIa. , 1986, Biochemistry.
[202] R. Machovich,et al. THROMBOMODULIN INHIBITS THE ACTIVATION OF FACTOR XIII BY THROMBIN. , 1986, Thrombosis and Haemostasis.
[203] K. Fujikawa,et al. Amino acid sequence of the b subunit of human factor XIII, a protein composed of ten repetitive segments. , 1986, Biochemistry.
[204] J. Mcdonagh,et al. Binding and covalent cross-linking of purified von Willebrand factor to native monomeric collagen. , 1986, The Journal of clinical investigation.
[205] K. Mann,et al. Factor V is a substrate for the transamidase factor XIIIa. , 1986, The Journal of biological chemistry.
[206] J. Mcdonagh,et al. Covalent crosslinking of von Willebrand factor to fibrin. , 1986, Blood.
[207] R. Ádány,et al. Identification of histiocytic reticulum cells by the immunohistochemical demonstration of factor XIII (F‐XIIIa) in human lymph nodes , 1986, The Journal of pathology.
[208] J. Mimuro,et al. Release of alpha 2-plasmin inhibitor from plasma fibrin clots by activated coagulation factor XIII. Its effect on fibrinolysis. , 1986, The Journal of clinical investigation.
[209] J. Takagi,et al. Platelet factor XIII. The collagen receptor? , 1986, The Journal of biological chemistry.
[210] M. Wojtukiewicz,et al. Fibrin stabilization, factor XIII transamidase activity and subunits "A" and "B" concentration in plasma of patients with liver cirrhosis. , 1986, Folia haematologica.
[211] M. Metsis,et al. Transglutaminase-sensitive glutamine residues of human plasma fibronectin revealed by studying its proteolytic fragments. , 1986, European journal of biochemistry.
[212] J. Nagy,et al. Biosynthesis of factor XIII B subunit by human hepatoma cell lines. , 1986, Blood.
[213] R. Procyk,et al. Factor XIII catalyzed formation of fibrinogen-fibronectin oligomers--a thiol enhanced process. , 1985, Thrombosis research.
[214] L. Lorand,et al. Regulation of formation of factor XIIIa by its fibrin substrates. , 1985, Biochemistry.
[215] C. Greenberg,et al. Regulation of plasma factor XIII binding to fibrin in vitro , 1985 .
[216] C. Greenberg,et al. The effect of fibrin polymers on thrombin-catalyzed plasma factor XIIIa formation. , 1985, Blood.
[217] P. Henriksson,et al. Identification of intracellular factor XIII in human monocytes and macrophages. , 1985, The Journal of clinical investigation.
[218] L. Patthy. Evolution of the proteases of blood coagulation and fibrinolysis by assembly from modules , 1985, Cell.
[219] R. Ádány,et al. Identification of blood coagulation factor XIII in human peritoneal macrophages. , 1985, European journal of cell biology.
[220] T. Tamaki,et al. Acceleration of fibrinolysis by the N-terminal peptide of alpha 2-plasmin inhibitor. , 1985, Blood.
[221] J. White,et al. Disulfide-linked and transglutaminase-catalyzed protein assemblies in platelets. , 1985, Blood.
[222] L. Westrick,et al. Incorporation of thrombospondin into fibrin clots. , 1985, The Journal of biological chemistry.
[223] M. Shuman,et al. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting. , 1985, The Journal of clinical investigation.
[224] R. Procyk,et al. FXIII induced gelation of human fibrinogen--an alternative thiol enhanced, thrombin independent pathway. , 1985, Thrombosis research.
[225] B. Horowitz,et al. Fibronectin and fibrin gel structure. , 1985, The Journal of biological chemistry.
[226] R. Ádány,et al. Factor XIII of blood coagulation in human monocytes. , 1985, Thrombosis research.
[227] Shirley A. Miller,et al. Gene frequency distribution of the B subunit of factor XIII (F XIIIB) in Minnesota Whites, Blacks and Amerindians , 1985 .
[228] P. Board,et al. An extended survey of the genetic polymorphism at the human coagulation factor XIII: a subunit structural locus. , 1985, Human heredity.
[229] M. Shuman,et al. Specific binding of blood coagulation factor XIIIa to thrombin-stimulated platelets. , 1984, The Journal of biological chemistry.
[230] F. Nagao,et al. [Factor XIII in the treatment of postoperative refractory wound-healing disorders. Results of a controlled study]. , 1984, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.
[231] H. Dvorak,et al. Quantitation of fibrinogen influx and fibrin deposition and turnover in line 1 and line 10 guinea pig carcinomas. , 1984, Cancer research.
[232] H. Geuze,et al. Immunocytochemical Localization of Albumin and Factor XIII in Thin Cryo Sections of Human Blood Platelets , 1984, Thrombosis and Haemostasis.
[233] J. Gorman,et al. Structural features of glutamine substrates for transglutaminases. Role of extended interactions in the specificity of human plasma factor XIIIa and of the guinea pig liver enzyme. , 1984, The Journal of biological chemistry.
[234] P. Board. Genetic heterogeneity of the B subunit of coagulation factor XIII: resolution of type 2 , 1984, Annals of human genetics.
[235] J. Mimuro,et al. Differential binding of plasminogen to crosslinked and noncrosslinked fibrins: its significance in hemostatic defect in factor XIII deficiency. , 1984, Blood.
[236] M. Losowsky,et al. Localisation of factor XIII in human tissues using an immunoperoxidase technique. , 1984, Journal of clinical pathology.
[237] C. Kluft,et al. The molecular form of alpha 2-antiplasmin with affinity for plasminogen is selectively bound to fibrin by factor XIII. , 1984, Thrombosis research.
[238] P. Harpel,et al. Inhibitors of the Fibrinolytic Enzyme System , 1984, Seminars in thrombosis and hemostasis.
[239] L. Lorand,et al. Promotion of thrombin-catalyzed activation of factor XIII by fibrinogen. , 1983, Biochemistry.
[240] D. Mosher,et al. SPECIFICITY OF FIBRONECTIN‐FIBRIN CROSS‐LINKING * , 1983, Annals of the New York Academy of Sciences.
[241] D. Mosher,et al. In vitro formation of disulfide-bonded fibronectin multimers. , 1983, The Journal of biological chemistry.
[242] P. Janmey,et al. Fibronectin. Effect of disulfide bond reduction on its physical and functional properties. , 1983, The Journal of biological chemistry.
[243] R. Nossal,et al. Effects of crosslinking on the rigidity and proteolytic susceptibility of human fibrin clots. , 1983, Thrombosis research.
[244] L. Lorand,et al. Contribution of fibrin stabilization to clot strength. Supplementation of factor XIII-deficient plasma with the purified zymogen. , 1983, The Journal of clinical investigation.
[245] L. McIntire,et al. Importance of plasma fibronectin in determining PFP and PRP clot mechanical properties. , 1983, Thrombosis research.
[246] K. Nitta,et al. CROSS-LINKING OF FIBRIN BY ACTIVATED FACTOR XIII STIMULATES ATTACHMENT, MORPHOLOGICAL CHANGES AND PROLIFERATION OF FIBROBLASTS , 1983 .
[247] J. E. Folk. Mechanism and basis for specificity of transglutaminase-catalyzed epsilon-(gamma-glutamyl) lysine bond formation. , 1983, Advances in enzymology and related areas of molecular biology.
[248] T. Tamaki,et al. Cross-linking of alpha 2-plasmin inhibitor to fibrin catalyzed by activated fibrin-stabilizing factor. , 1982, Journal of Biological Chemistry.
[249] N. Aoki,et al. Reversible cross-linking of α2-plasmin inhibitor to fibrinogen by fibrin-stabilizing factor , 1982 .
[250] M. Shuman,et al. The zymogen forms of blood coagulation factor XIII bind specifically to fibrinogen. , 1982, The Journal of biological chemistry.
[251] Y. Sakata,et al. Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis. , 1982, The Journal of clinical investigation.
[252] H. Bruhn. Growth regulation of vessel wall cells and of tumor cells by thrombin, factor XIII and fibronectin. , 1981, Thrombosis and haemostasis.
[253] S. Ikematsu. An approach to the metabolism of factor XIII. , 1981, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society.
[254] J. Baguet,et al. Skin healing and fibrin stabilizing factor blood levels in the rabbit fetus. , 1981, The Journal of surgical research.
[255] T. Tamaki,et al. Cross-linking of α2-plasmin inhibitor and fibronectin to fibrin by fibrin-stabilizing factor , 1981 .
[256] T. Juji,et al. Genetic polymorphism of the a subunit of human coagulation factor XIII in Japanese , 1981, Japanese Journal of Human Genetics.
[257] A. Veis,et al. Ca2+-dependent cross-linking processes in human platelets. , 1981, Biochimica et biophysica acta.
[258] L. Lorand,et al. Alpha-chain domain of fibrinogen controls generation of fibrinoligase (coagulation factor XIIIa). Calcium ion regulatory aspects. , 1981, Biochemistry.
[259] J. Mcdonagh,et al. Amino acid sequence of the factor XIIIa acceptor site in bovine plasma fibronectin , 1981, FEBS letters.
[260] J. Gorman,et al. Structural features of glutamine substrates for transglutaminases. Specificities of human plasma factor XIIIa and the guinea pig liver enzyme toward synthetic peptides. , 1981, The Journal of biological chemistry.
[261] L. Lorand,et al. Modification of shear modulus and creep compliance of fibrin clots by fibronectin. , 1981, Biophysical chemistry.
[262] J. Hermans,et al. Cross-linked fibrinogen dimers demonstrate a feature of the molecular packing in fibrin fibers. , 1981, Science.
[263] L. Glynn. Tissue repair and regeneration , 1981 .
[264] A. Bloom. Haemostasis and thrombosis , 1981 .
[265] H. Miyata,et al. Plasma factor XIII levels in children with renal disease. , 1981, Nephron.
[266] L. Lorand,et al. Factor XIII (fibrin-stabilizing factor). , 1981, Methods in enzymology.
[267] T. Newcomb,et al. Clot retraction in a factor XIII free system. , 2009, Scandinavian journal of haematology.
[268] J. E. Folk,et al. Half-of-the-sites and all-of-the-sites reactivity in human plasma blood coagulation factor XIIIa. , 1980, The Journal of biological chemistry.
[269] R. Nossal,et al. Rigidity of fibrin gels as measured by quasielastic light scattering , 1980, Biopolymers.
[270] F. Grinnell,et al. Fibroblast adhesion to fibrinogen and fibrin substrata: Requirement for cold-insoluble globulin (plasma fibronectin) , 1980, Cell.
[271] Y. Sakata,et al. Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor. , 1980, The Journal of clinical investigation.
[272] A. Veis,et al. Factor XIIIa-catalyzed cross-linking of platelet and muscle actin. Regulation by nucleotides. , 1980, Biochimica et biophysica acta.
[273] J. Shainoff,et al. Crosslinking of Monomeric Fibrin by Factor XIIIa , 1979, Thrombosis and Haemostasis.
[274] D. Mosher,et al. Cross-linking of fibronectin to collagen by blood coagulation Factor XIIIa. , 1979, The Journal of clinical investigation.
[275] Board Pg. Genetic polymorphism of the A subunit of human coagulation factor XIII. , 1979 .
[276] P. Gaffney,et al. Fibrin crosslinks and lysis rates. , 1979, Thrombosis research.
[277] G. Siefring,et al. Fibrinoligase-catalyzed cross-linking of myosin from platelet and skeletal muscle. , 1979, Archives of biochemistry and biophysics.
[278] L. Lorand,et al. Ca2+-related regulatory function of fibrinogen. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[279] D. Nyman,et al. Quantitative Estimation of Coagulation Factors in Liver Disease. The Diagnostic and Prognostic Value of Factor XIII, Factor V and Plasminogen , 1978, Thrombosis and Haemostasis.
[280] T. Urayama,et al. The role of factor XIII in fibroblast proliferation. , 1978, The Japanese journal of experimental medicine.
[281] J. Finlayson,et al. The ɛ-(γ-Glutamyl)Lysine Crosslink and the Catalytic Role of Transglutaminases , 1977 .
[282] M. Losowsky,et al. Plasma Factor XIII and Platelet Factor XIII in Hyperlipaemia , 1976, Thrombosis and Haemostasis.
[283] A. Vaheri,et al. Cross-linking of a major fibroblast surface-associated glycoprotein (fibronectin) catalyzed by blood coagulation factor XIII , 1976, Cell.
[284] J. Mcdonagh,et al. Subcellular distribution of fibrinogen and factor XIII in human blood platelets. , 1976, Thrombosis research.
[285] Ş. Ozsoylu,et al. Platelet aggregation in congenital factor XIII deficiency. , 1976, Acta haematologica.
[286] H. Kanaide,et al. Cross-linking of fibrinogen and fibrin by fibrin-stablizing factor (factor XIIIa). , 1976, The Journal of laboratory and clinical medicine.
[287] F. Haverkate. Lysis of Crosslinked and Non-Crosslinked Purified Fibrin , 1975, Thrombosis and Haemostasis.
[288] P. Cohen,et al. Distribution of Fibrinogen, and Platelet Factors 4 and XIII in Subcellular Fractions of Human Platelets , 1975, British journal of haematology.
[289] D. Mosher. Cross-linking of cold-insoluble globulin by fibrin-stabilizing factor. , 1975, The Journal of biological chemistry.
[290] J. Hermans,et al. Effects of calcium ion and covalent crosslinking on formation and elasticity of fibrin cells. , 1975, Thrombosis research.
[291] R. Ross,et al. The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. , 1975, The American journal of pathology.
[292] B. Rudas,et al. The Effect of Factor XIII on Wound Granulation in the Rat , 1974, Thrombosis and Haemostasis.
[293] H. Hartert. Rheo-simulation: a new method for the assay of clotting process and factor XIII. A preliminary report. , 1974, Biorheology.
[294] R. Cooke. Calcium-induced dissociation of human plasma factor XIII and the appearance of catalytic activity. , 1974, The Biochemical journal.
[295] L. Lorand,et al. Fibrin-stabilizing Factor (Factor XIII) in the Fetus and the Newborn Infant , 1974, Pediatric Research.
[296] L. Lorand,et al. Calcium-dependent unmasking of active center cysteine during activation of fibrin stabilizing factor. , 1974, Biochemistry.
[297] K. Zimmermann,et al. Prophylaxe postoperativer Wundheilungsstörungen durch Faktor-XIII-Substitution , 1974 .
[298] P. Kierulf,et al. Stabilization of soluble fibrin-fibrinogen complexes by fibrin stabilizing factor (FSF). , 1974, Thrombosis research.
[299] S. I. Chung,et al. Relationships of the catalytic properties of human plasma and platelet transglutaminases (activated blood coagulation factor XIII) to their subunit structures. , 1974, The Journal of biological chemistry.
[300] J. Joist,et al. Retention of Platelet Fibrin Stabilizing Factor during the Platelet Release Reaction and Clot Retraction , 1973, Thrombosis and Haemostasis.
[301] S. Chung. COMPARATIVE STUDIES ON TISSUE TRANSGLUTAMINASE AND FACTOR XIII , 1972, Annals of the New York Academy of Sciences.
[302] R. Wagner,et al. DEMONSTRATION OF FACTOR XIII IN HUMAN MEGAKARYOCYTES BY A FLUORESCENT ANTIBODY TECHNIQUE * , 1972, Annals of the New York Academy of Sciences.
[303] J. Mcdonagh,et al. The Influence of Fibrin Crosslinking on the Kinetics of Urokinase‐Induced Clot Lysis * , 1971, British journal of haematology.
[304] S. Pizzo,et al. The effect of fibrin-stabilizing factor on the subunit structure of human fibrin. , 1971, The Journal of clinical investigation.
[305] H. Schwarz,et al. Faktor-XIII-Konzentration und Wundheilung* , 1970 .
[306] K. W. Henderson,et al. The Mechanism of Enhanced Streptokinase‐Induced Clot Lysis following In‐vitro Factor‐XIII Inactivation , 1969, British journal of haematology.
[307] Losowsky Ms,et al. Plasma fibrin stabilising factor (F.S.F.) activity in normal subjects and patients with chronic liver disease. , 1969 .
[308] A. Fletcher,et al. Enzymic lysis of plasma clots: The influence of fibrin stabilization on lysis rates , 1967 .
[309] M. Rikover,et al. Factor 13 deficiency with severe hemorrhagic diathesis. , 1966, Blood.
[310] L. Lorand,et al. Labeling of amine-acceptor cross-linking sites of fibrin by transpeptidation. , 1966, Biochemistry.
[311] L. Lorand,et al. Accelerated Lysis of Blood Clots , 1962, Nature.
[312] F. Duckert,et al. The Influence of Fibrin Stabilizing Factor on the Growth of Fibroblats in vitro and Wound Healing , 1961, Thrombosis and Haemostasis.
[313] A. Loewy,et al. Fibrinase. IV. Effect on fibrin solubility. , 1961, The Journal of biological chemistry.
[314] A. Loewy,et al. Fibrinase. I. Purification of substrate and enzyme. , 1961, The Journal of biological chemistry.
[315] A. Loewy,et al. Fibrinase III. Some enzymatic properties. , 1961, The Journal of biological chemistry.
[316] A. Loewy,et al. Fibrinase. II. Some physical properties. , 1961, The Journal of biological chemistry.
[317] F. Duckert,et al. A Hitherto Undescribed Congenital Haemorrhagic Diathesis Probably Due to Fibrin Stabilizing Factor Deficiency , 1961, Thrombosis and Haemostasis.
[318] C. Veneziale,et al. Purification of the factor involved in the formation of urea-insoluble fibrin. , 1957, Biochimica et biophysica acta.
[319] Lüscher Ef. [Fibrin-stabilizing factor from thrombocytes]. , 1957 .
[320] L. Lorand,et al. On the Solubility of Fibrin Clots. , 1948, Science.
[321] L. Lorand. A study on the solubility of fibrin clots in urea. , 1948, Hungarica acta physiologica.
[322] K. Robbins. A STUDY ON THE CONVERSION OF FIBRINOGEN TO FIBRIN , 1944 .
[323] J. Mellanby,et al. Calcium and blood coagulation , 1940, Proceedings of the Royal Society of London. Series B - Biological Sciences.